IONS (Ionis Pharmaceuticals, Inc. Common Stock) Stock Analysis - Insider Trades
Ionis Pharmaceuticals, Inc. Common Stock (IONS) is a publicly traded Healthcare sector company. As of May 21, 2026, IONS trades at $75.44 with a market cap of $11.98B and a P/E ratio of 74.97. IONS moved +1.63% today. Year to date, IONS is -4.42%; over the trailing twelve months it is +117.75%. Its 52-week range spans $23.95 to $86.74. Analyst consensus is strong buy with an average price target of $105.94. Rallies surfaces IONS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading IONS stock inside the company?
Recent IONS insider activity includes Monia Brett P sold 3.22K, Monia Brett P sold 1.32K, LOSCALZO JOSEPH sold 59.51K, LOSCALZO JOSEPH sold 17.78K, and KLEIN JOSEPH III sold 8.68K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
IONS Key Metrics
Key financial metrics for IONS
Metric
Value
Price
$75.44
Market Cap
$11.98B
P/E Ratio
74.97
EPS
$1.00
Dividend Yield
0.00%
52-Week High
$86.74
52-Week Low
$23.95
Volume
473
Avg Volume
0
Revenue (TTM)
$1.06B
Net Income
$154.57M
Gross Margin
98.35%
Recent IONS Insider Trades
Monia Brett P sold 3.22K (~$253.35K) on May 14, 2026.
Monia Brett P sold 1.32K (~$102.67K) on May 13, 2026.
LOSCALZO JOSEPH sold 59.51K (~$4.46M) on May 4, 2026.
LOSCALZO JOSEPH sold 17.78K (~$1.34M) on May 4, 2026.
KLEIN JOSEPH III sold 8.68K (~$636.70K) on May 1, 2026.
Recent IONS insider activity includes Monia Brett P sold 3.22K, Monia Brett P sold 1.32K, LOSCALZO JOSEPH sold 59.51K, LOSCALZO JOSEPH sold 17.78K, and KLEIN JOSEPH III sold 8.68K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for IONS?
Yes. Rallies tracks IONS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is IONS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IONS. It does not provide personalized investment advice.